Literature DB >> 33589104

Management and Cure of Gouty Arthritis.

Sarah F Keller1, Brian F Mandell2.   

Abstract

Gout is the most common inflammatory arthritis in the United States. Gouty arthritis is associated with significant morbidity and mortality and is caused by hyperuricemia. Gout is effectively managed and potentially cured by decreasing the overall urate burden with serum urate-lowering therapy. When serum urate is maintained at less than 6.0 mg/dL urate deposition is resolved and gout can be cured. Unfortunately, owing to a lack of physician monitoring and dose escalation the majority of patients do not achieve these urate levels.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gout; Hyperuricemia; Inflammatory arthritis; Treat-to-target; Uric acid

Mesh:

Substances:

Year:  2021        PMID: 33589104     DOI: 10.1016/j.mcna.2020.09.013

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  2 in total

Review 1.  Promising Strategies for Transdermal Delivery of Arthritis Drugs: Microneedle Systems.

Authors:  Jitong Wang; Jia Zeng; Zhidan Liu; Qin Zhou; Xin Wang; Fan Zhao; Yu Zhang; Jiamiao Wang; Minchen Liu; Ruofei Du
Journal:  Pharmaceutics       Date:  2022-08-19       Impact factor: 6.525

2.  Identification of Interleukin-1-Beta Inhibitors in Gouty Arthritis Using an Integrated Approach Based on Network Pharmacology, Molecular Docking, and Cell Experiments.

Authors:  Liying Zeng; Zekun Lin; Pan Kang; Meng Zhang; Hongyu Tang; Miao Li; Kun Xu; Yamei Liu; Ziyun Jiang; Shaochuan Huo
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-19       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.